[Liver transplantation: personalized immunosuppression in patients with hepatitis C virus infection and hepatocellular carcinoma].


Transplantation has become the treatment of choice in end-stage liver disease, with 5-year survival rates of around 68-74% in European and North-American registries (www.unos.org, www.eltr.org, www.ont.es). These results are largely due to the development of powerful immunosuppressive agents, mainly calcineurin inhibitors. However, these immunosuppressive… (More)
DOI: 10.1016/j.gastrohep.2012.03.006


Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.

Slides referencing similar topics